← Back to Bills
H.R. 6664House119th Congress (2025-2027)In Committee

To establish a Biotechnology Management Office in the Department of Defense and to provide support for the research and development of bioindustrial manufacturing processes, and for other purposes.

Sponsored by Joe NeguseRep. Joe Neguse (D-CO)
Introduced December 11, 2025

AI-Generated Summary

Updated January 4, 2026 at 6:21 AM UTC

The bill creates a new Biotechnology Management Office within the Department of Defense to coordinate and advance the department’s use of biotechnology. It also authorizes the use of defense research funds for bioindustrial manufacturing research and development. The office and funding provisions would affect DoD personnel, contractors, academia, industry partners, and other federal agencies involved in biotechnology.

Key Provisions

  • Within 90 days of enactment, the Secretary of Defense must appoint a senior official with biotechnology experience to lead the new office.
  • Within 120 days, the Secretary must establish the Biotechnology Management Office under the Deputy Secretary’s authority.
  • The office will develop a long‑term roadmap, update acquisition policies, coordinate with government, industry and academia, streamline regulatory processes, conduct competition analyses, foster public‑private partnerships, and identify workforce training gaps.
  • The office and its duties will expire on September 30, 2030, and the Secretary must brief congressional defense committees on its charter and initial plans within 30 days of the senior official’s appointment.
  • The bill amends the 2023 National Defense Authorization Act to allow DoD research, development, test, and evaluation funds to be used for bioindustrial manufacturing projects.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

1 earlier action
HouseIntro Referral Latest Action

Referred to the House Committee on Armed Services.

Armed Services Committee

December 11, 2025

View full timeline
HouseIntro Referral

Introduced in House

December 11, 2025

HouseIntro Referral

Referred to the House Committee on Armed Services.

Armed Services Committee

December 11, 2025

Bill Text

Latest available legislative text

Reading Mode
Latest
Raw Text PDF XML
Introduced in HouseIssued December 11, 2025

I

119th CONGRESS

1st Session

H. R. 6664

IN THE HOUSE OF REPRESENTATIVES

December 11, 2025

Mr. Neguse introduced the following bill; which was referred to the Committee on Armed Services

A BILL

To establish a Biotechnology Management Office in the Department of Defense and to provide support for the research and development of bioindustrial manufacturing processes, and for other purposes.

1.

Biotechnology Management Office

(a)

Designation of senior official

Not later than 90 days after the date of the enactment of this Act, the Secretary of Defense shall designate a senior official, with relevant biotechnology experience, from a position within the Department of Defense that was in effect on the day before the date of the enactment of this Act, to—

(1)

be the senior official for biotechnology issues;

(2)

be the head of the Biotechnology Management Office established under subsection (b); and

(3)

carry out the responsibilities for the office in subsection (c).

(b)

Establishment of Biotechnology Management Office

Not later than 120 days after the date of the enactment of this Act, the Secretary of Defense shall, with input from the senior official designated under subsection (a), charter and establish, under the authority, direction, and control of the Deputy Secretary of Defense, a Biotechnology Management Office to foster the development, acquisition, and sustainment of broad-based biotechnology capabilities for the Department.

(c)

Responsibilities

The office established under subsection (b) shall be responsible for the following:

(1)

Maintaining and executing a long-term research, development, acquisition, and sustainment roadmap.

(2)

Updating policies and guidance within the Department relating to the acquisition, adoption, and transition of biotechnology-based products into Department use.

(3)

Coordinating with activities across the Department, the Federal Government, industry, academia, and international partners relating to biotechnology.

(4)

Proposing options for streamlining the regulatory or acquisition process of the Department.

(5)

Conducting, as may be needed, global competition analyses, net assessment, or forecasting to support decisionmakers on biotechnology advances.

(6)

Supporting the development of public-private partnerships with academia, industry, and other State and local government partners, including through the development or fostering of regionally focused innovation ecosystems.

(7)

Identifying biotechnology workforce and training gaps across the workforce of the Department.

(8)

Such other responsibilities as the Secretary considers appropriate.

(d)

Sunset

This section shall terminate on September 30, 2030.

(e)

Briefing

Not later than 30 days after the designation of the senior official pursuant to subsection (a), the Secretary shall provide to the congressional defense committees a briefing on the proposed scope of the charter for the office to be established pursuant to subsection (b), as well as implementation plans for preliminary activities the office will pursue during the proceeding one-year period.

2.

Support for research and development of bioindustrial manufacturing processes

Section 215 of the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023 (Public Law 117–263; 10 U.S.C. 4841 note) is amended—

(1)

by redesignating subsections (d) through (f) as subsections (e) through (g), respectively; and

(2)

by inserting after subsection (c) the following new subsection:

(d)

Funding

Funds authorized to be appropriated or otherwise made available to the Department of Defense for research, development, test, and evaluation may be used to carry out the activities described in subsection (c), including the design and construction activities described in subsection (c).

.